| 14.905 0.005 (0.03%) | 09-16 12:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 18.39 | 1-year : | 21.48 |
| Resists | First : | 15.75 | Second : | 18.39 |
| Pivot price | 14.61  |
|||
| Supports | First : | 13.78 | Second : | 12.56 |
| MAs | MA(5) : | 14.98  |
MA(20) : | 14.32 |
| MA(100) : | 18.24 |
MA(250) : | 19.68 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 68.3 |
D(3) : | 70.9 |
| RSI | RSI(14): 45.8 |
|||
| 52-week | High : | 30.93 | Low : | 12.56 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ USNA ] has closed below upper band by 35.9%. Bollinger Bands are 52.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 15.26 - 15.35 | 15.35 - 15.43 |
| Low: | 14.66 - 14.75 | 14.75 - 14.84 |
| Close: | 14.76 - 14.92 | 14.92 - 15.05 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Mon, 14 Sep 2026
USNA - Usana Health Sciences Inc Revenue Breakdown - Finviz
Mon, 14 Sep 2026
Implied Volatility Surging for USANA Health Stock Options - TradingView
Fri, 04 Sep 2026
Empowered Funds LLC Invests $1.50 Million in USANA Health Sciences, Inc. $USNA - MarketBeat
Wed, 02 Sep 2026
1,554,189 Shares in USANA Health Sciences, Inc. $USNA Bought by BlackRock Inc. - MarketBeat
Tue, 01 Sep 2026
USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act - Stock Titan
Sun, 09 Aug 2026
Why Usana Health Sciences Stock Plummeted This Week - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 18 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 40.8 (%) |
| Held by Institutions | 63.3 (%) |
| Shares Short | 756 (K) |
| Shares Short P.Month | 753 (K) |
| EPS | -1.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.51 |
| Profit Margin | -2.5 % |
| Operating Margin | 4 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | -5.1 % |
| Qtrly Rev. Growth | -5.4 % |
| Gross Profit (p.s.) | 38.27 |
| Sales Per Share | 49.42 |
| EBITDA (p.s.) | 4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 28 (M) |
| Levered Free Cash Flow | 49 (M) |
| PE Ratio | -12.62 |
| PEG Ratio | 0.6 |
| Price to Book value | 0.52 |
| Price to Sales | 0.3 |
| Price to Cash Flow | 9.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|